These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 16858404
41. Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1. Jang H, Choi DE, Kim H, Cho EJ, Youn HD. J Biol Chem; 2007 Apr 13; 282(15):11172-9. PubMed ID: 17172641 [Abstract] [Full Text] [Related]
42. Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Kang MY, Lee BB, Kim YH, Chang DK, Kyu Park S, Chun HK, Song SY, Park J, Kim DH. Int J Cancer; 2007 Nov 15; 121(10):2192-7. PubMed ID: 17657744 [Abstract] [Full Text] [Related]
43. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. García-Cao M, O'Sullivan R, Peters AH, Jenuwein T, Blasco MA. Nat Genet; 2004 Jan 15; 36(1):94-9. PubMed ID: 14702045 [Abstract] [Full Text] [Related]
44. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Bergstrom DA, Tapscott SJ. Mol Cell Biol; 2001 Apr 15; 21(7):2404-12. PubMed ID: 11259589 [Abstract] [Full Text] [Related]
45. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration. Zhang RH, Judson RN, Liu DY, Kast J, Rossi FM. Skelet Muscle; 2016 Apr 15; 6():22. PubMed ID: 27239264 [Abstract] [Full Text] [Related]
46. [Experimental study of SUV39H1 gene specific siRNA in human leukemia cell line]. Zhao T, Ma XD, Huang YQ. Zhonghua Xue Ye Xue Za Zhi; 2013 Jan 15; 34(1):49-54. PubMed ID: 23597465 [Abstract] [Full Text] [Related]
47. The epigenetic control of stemness in CD8+ T cell fate commitment. Pace L, Goudot C, Zueva E, Gueguen P, Burgdorf N, Waterfall JJ, Quivy JP, Almouzni G, Amigorena S. Science; 2018 Jan 12; 359(6372):177-186. PubMed ID: 29326266 [Abstract] [Full Text] [Related]
50. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Chiba T, Saito T, Yuki K, Zen Y, Koide S, Kanogawa N, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Iwama A, Yokosuka O. Int J Cancer; 2015 Jan 15; 136(2):289-98. PubMed ID: 24844570 [Abstract] [Full Text] [Related]
55. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Myer A, Olson EN, Klein WH. Dev Biol; 2001 Jan 15; 229(2):340-50. PubMed ID: 11203698 [Abstract] [Full Text] [Related]
56. c-Myb inhibits myogenic differentiation through repression of MyoD. Kaspar P, Pajer P, Sedlak D, Tamaoki T, Dvorak M. Exp Cell Res; 2005 Oct 01; 309(2):419-28. PubMed ID: 16055116 [Abstract] [Full Text] [Related]
57. p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program. Gillespie MA, Le Grand F, Scimè A, Kuang S, von Maltzahn J, Seale V, Cuenda A, Ranish JA, Rudnicki MA. J Cell Biol; 2009 Dec 28; 187(7):991-1005. PubMed ID: 20026657 [Abstract] [Full Text] [Related]
58. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases. Kobayashi N, Goto K, Horiguchi K, Nagata M, Kawata M, Miyazawa K, Saitoh M, Miyazono K. Genes Cells; 2007 Mar 28; 12(3):375-85. PubMed ID: 17352741 [Abstract] [Full Text] [Related]